Home

Content about BIO International Convention

July 19, 2012
Building Biotech Hubs; Biomanufacturing Attractors and Accelerators

Bioscience economic development in a nation as large and diverse as the United States is as varied as the country itself.  A complex array of factors influence the allocation of resources and the nature of bioscience industry development.

This is the fourth in a series of articles on workforce development and quality jobs - with a focus on state and regional support for bioscience industry development. Read part one. Read part two. Read part three.

By Peter M. Pellerito, BIO Senior Policy Consultant

June 14, 2012
Meet the BIO Official Bloggers

For the fourth year in a row, BIO is working with bloggers and reporters from around the country (and Canada) to provide attendees with an inside look of what’s happening in Boston.

With so much happening at the 2012 BIO International Convention it can be difficult to keep track of it all.  For the fourth year in a row, BIO is working with bloggers and reporters from around the country (and Canada) to provide attendees with an inside look of what’s happening in Boston.

Each of them leaders in their fields, these independent bloggers and reporters will provide their thought-provoking insights on everything taking place at Convention, from news being made on the show floor to our Super Sessions to reports and surveys being released.

December 19, 2011
60 Pavilions Showcase Countries, Regions and States at the 2012 BIO International Convention

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

North Carolina Pavilion Brings Small Biotech Companies

December 13, 2011
BIO One-on-One Partnering

The biotechnology and pharmaceutical industries are continuously trying to improve efficiency in access to industry knowledge, innovation, and therapies.

The biotechnology and pharmaceutical industries are continuously trying to improve efficiency in access to industry knowledge, innovation, and therapies.  Partnering is the technological solution to this problem.  In a resource constrained environment, BIO One-on-One Partnering exists to ensure that companies of all shapes and sizes are able to have better and more meaningful access to potential partners from all over the globe.  This leads to a more productive conference experience, and BIO is proud to be a leader in the partnering field.

November 10, 2011
Session Submission Update: Where Are We Now?

With the overwhelming success of our recent Call for Sessions, next year’s BIO International Convention may be the best yet!

With the overwhelming success of our recent Call for Sessions, next year’s BIO International Convention may be the best yet!

Companies, institutions, and organizations from around the globesubmitted more than 500 entries to host a session at the Convention. Word has quickly spread that for an organization to maximize visibility and credibility among the most influential people in the industry, becoming a session host is invaluable.

October 19, 2011
The Power of Partnering, Expanded

Where can you network and partner with 15,000+ industry leaders from 65 countries across the globe?

Where can you network and partner with 15,000+ industry leaders from 65 countries across the globe?

The 2012 BIO International Convention, June 18-21, in Boston, Mass. is the global marketplace where you can stay on the forefront of biotech's most important developments through our education, BIO Exhibiton, networking events, and the BIO Business Forum powered by BIO One-on-One Partnering.

September 28, 2011
Submit your 2012 BIO International Convention Session Proposal Today

Got questions regarding the submission process? We’ve got the answers! Here are a few of the most frequently asked questions regarding submitting a proposal.

Don’t miss your chance to host a session at the 2012 BIO International Convention! With 15,000+ biotechnology professionals in attendance, a diverse audience representing 50 states and 65 countries, and representatives from the world’s top pharmaceutical companies, there is no better opportunity to gain publicity and credibility with the most influential people in the industry.

August 26, 2011
You’re On: Three Reasons to Organize a Session at BIO

What event featured CNN’s Fareed Zakaria, Former DNC Chairman Howard Dean, Republic Strategist Karl Rove, Former British Prime Minister Tony Blair, and the heads of the largest pharmaceutical manufacturers in the world?

June 21, 2011
2011 BIO International Convention Preview
June 7, 2011
BIO International Convention

BIO International Convention

The annual BIO International Convention is the largest global event for the biotechnology industry. The Convention attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

June 7, 2011
Elana Fine, University of Maryland Dingman Center for Entrepreneurship and local co-chair of the 7th Annual Biotechnology Entrepreneurship Boot Camp

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International convention is an intensive three day course designed for entrepreneurial scientists, CEOs, CSOs and business development professionals of early stage companies in the life sciences who are aspiring entrepreneurs.

June 7, 2011
Elana Fine, University of Maryland Dingman Center for Entrepreneurship and local co-chair of the 7th Annual Biotechnology Entrepreneurship Boot Camp

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International convention is an intensive three day course designed for entrepreneurial scientists, CEOs, CSOs and business development professionals of early stage companies in the life sciences who are aspiring entrepreneurs.

The Biotechnology Entrepreneurship Boot Camp at the 2011 BIO International convention is an intensive three day course designed for entrepreneurial scientists, CEOs, CSOs and business development professionals of early stage companies in the life sciences who are aspiring entrepreneurs.

Fine discusses the upcoming Boot Camp, who should attend and what they can expect to learn.

June 6, 2011
Get Active at the 2011 BIO International Convention

According to the American College of Sports Medicine, Washington, DC tops the ranks of the fittest cities in the nation. With the 2011 BIO International Convention quickly approaching, BIO hopes visitors will get active.  From the BIO 5K Run/Walk to the BIO Golf Outing (both hosted by Novo Nordisk Inc) to the various outdoor activities right at our fingertips in the nation’s capital, attendees are encouraged to get outside and take advantage of all the city has to offer.

June 3, 2011
Deb Bowes, President of Women in Bio

Deb Bowes from Women in Bio discusses plans for the upcoming BIO International Convention, the critical role of women’s leadership in biotechnology, and why she is personally committed to Women in Bio and its mission.

Deb Bowes from Women in Bio discusses plans for the upcoming BIO International Convention, the critical role of women’s leadership in biotechnology, and why she is personally committed to Women in Bio and its mission.

June 3, 2011
Dr. Jeffrey Almond, Vice president of Discovery and External R&D for Sanofi Pasteur

BIOtechNOW’s Tracy Cooley talks to Dr. Almond of Sanofi Pasteur about the International BioGENEius Challenge, which will be presented at the upcoming BIO International Convention.

May 25, 2011
Bob Klein, 2010 Biotechnology Humanitarian Award Winner

Klein is chairman of the governing board and a member of the peer review committee for the  California Institute for Regenerative Medicine. The Biotechnology Humanitarian Award is given out each year at the BIO International Convention .

Klein is chairman of the governing board and a member of the peer review committee for the  California Institute for Regenerative Medicine. The Biotechnology Humanitarian Award is given out each year at the BIO International Convention .

May 25, 2011
Dr. Jay Siegel and Janelle Curtis discuss this year’s International BioGENEius Challenge

Dr. Jay Siegel of  Johnson & Johnson Pharmaceutical Research & Development  and Janelle Curtis from the  Biotechnology Institute  discuss this year’s International BioGENEius Challenge.

Dr. Jay Siegel of  Johnson & Johnson Pharmaceutical Research & Development  and Janelle Curtis from the  Biotechnology Institute  discuss this year’s International BioGENEius Challenge.

May 21, 2011
New Diabetes Forum at the 2011 BIO International Convention

The number of Americans diagnosed with diabetes — the seventh leading cause of death in the U.S. — has risen by epidemic proportions. In addition, the disease is estimated to affect 435 million people worldwide by 2030. BIO and the Juvenile Diabetes Research Foundation will feature a two-day diabetes forum for the first time at the 2011 BIO International Convention in Washington, DC. The sessions will showcase the latest research in novel therapies, vaccines, and biomarkers.

May 21, 2011
Worldview: A Global Biotechnology Perspective

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

May 17, 2011
Staying Ahead of the Legal and Regulatory Curve

Providing legal counsel within the biotech industry comes with a unique set of challenges.  Legal professionals must consistently stay on top of the latest policy and regulatory changes within the industry. From patent issues to new laws on licensing to regulations for new innovations, the BIO International Convention (June 27-30) will feature the latest updates, insights and networking opportunities—plus educational sessions where you can earn up to eight CLE credit hours—to help fast-track your career. Sit in on any number of BIO Program presentations by leading law firms and earn CLE credits.

May 12, 2011
The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the  BIO International Convention  next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets.

May 9, 2011
Lovell Jones, PhD – 2011 Humanitarian Award judge

BIOtechNOW’s Tracy Cooley talks to Dr. Jones about the significance and importance of the re; Biotech Humanitarian Award , which will be bestowed on this year’s award winner at the  BIO International Convention during a keynote session on Wednesday, June 29.

May 5, 2011
BIO and USPTO Trace the Journey of Biotech Inventions

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S. patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S. patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.  The event will be held during the BIO International Convention on the morning of Thursday, June 30, at the Walter E. Washington Convention Center in Washington, D.C. 

April 27, 2011
A Conversation with the Michael J. Fox Foundation for Parkinson's Research

April is Parkinson's Awareness Month so it seemed like a good opportunity to learn more about the Michael J. Fox Foundation for Parkinson's Research.

April is Parkinson's Awareness Month so it seemed like a good opportunity to learn more about the Michael J. Fox Foundation for Parkinson's Research.

April 27, 2011
Scientific American Worldview 2011 Preview -- New this year: Three pioneers share keys to success for building biotech in emerging markets

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India.

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India. This year’s report will profile:

Guilherme Emrich, FIR Capital (Brazil)

Ge Li, WuXi Apptec (China)

Kiran Mazumdar-Shaw, Biocon (India)

Their opinions and advice on a diverse range of subjects is explored in a Q&A while their individual stories are told in accompanying profiles.  Don’t miss this special section in the Worldview 2011 report.